HIPERTENSI - Farmakoterapi

download HIPERTENSI - Farmakoterapi

of 9

Transcript of HIPERTENSI - Farmakoterapi

  • 8/13/2019 HIPERTENSI - Farmakoterapi

    1/9

    10/26/20

    HIPERTENSI

    DEFINISI

    Blood pressure:

    is the pressure of the blood against the walls of thearteries.

    results fro two for!es. "ne is !reated b# the heart as it pups blood into the arteries

    and through the !ir!ulator# s#ste.

    The other is the for!e of the arteries as the# resist the bloodflow.

    Te$anan darah

    S#stoli! blood pressure is a easure of bloodpressure while the heart is beating

    Diastoli! pressure is a easure of blood pressurewhile the heart is rela%ed& between heartbeats.

    TEKANAN DARAH

    CARDIAC OUTPUT RESISTENSI PERIFER

  • 8/13/2019 HIPERTENSI - Farmakoterapi

    2/9

    10/26/20

    HIPERTENSI

    H#pertension is defined b# persistent ele'ation ofarterial blood pressure (BP).

    The Se'enth Report of the *oint National +oittee

    on the Dete!tion& E'aluation& and Treatent of HighBlood Pressure (*N+ ,) !lassifies adult BP

    isolated s#stoli! h#pertension: Patients with diastoli!blood pressure (DBP) 'alues -/ Hg ands#stoli! blood pressure (SBP) 'alues 012/ Hg

    3 h#pertensi'e !risis (BP 415/617/ Hg) a# be!ategori8ed as either :

    a h#pertensi'e eergen!# (e%tree BP ele'ation

    with a!ute or progressing target organ daage) or

    a h#pertensi'e urgen!# (se'ere BP ele'ation without

    a!ute or progressing target organ in9ur#)

    PRE3;ENSI D3N EPIDE

  • 8/13/2019 HIPERTENSI - Farmakoterapi

    3/9

    10/26/20

    P3T"FISI";"=I

  • 8/13/2019 HIPERTENSI - Farmakoterapi

    4/9

    10/26/20

    "

  • 8/13/2019 HIPERTENSI - Farmakoterapi

    5/9

  • 8/13/2019 HIPERTENSI - Farmakoterapi

    6/9

    10/26/20

    3lgorita terapi hipertensi

    Ora) antihypertensi8e .r/gs9

    C)ass Dr/g ,Tra.e Na(e- Us/a) .se range in (g5.ay ,Dai)y Fre:/en*y-

    ACE inhi4itrs

    bena&e#$il '(otensin)* 10+%0 '1+2*

    ,a#to#$il 'Ca#oten)* 25+100 '2*

    enala#$il '-asote,)* 2.5+%0 '1+2*osino#$il 'Mono#$il* 10+%0 '1*

    lisino#$il '$iniil est$il)* 10+%0 '1*oei#$il '4nias,* 7.5+30 '1*

    #e$indo#$il 'A,eon* %+8 '1+2*

    uina#$il 'A,,u#$il* 10+%0 '1*

    $ai#$il 'Alta,e* 2.5+20 '1*

    t$andola#$il 'Mai* 1+% '1*

    Angitensin II antagnists

    ,andesa$tan 'Ata,and* 8+32 '1*

    e#$osa$tan 'eetan* %00+800 '1+2*i$besa$tan 'Aa#$o* 150+300 '1*

    losa$tan 'Co&aa$* 25+100 '1+2*

    olesa$tan 'eni,a$* 20+%0 '1*telisa$tan 'Mi,a$dis* 20+80 '1*alsa$tan 'ioan* 80+320 '1*

    C)assii*atinC)assii*atin

    Ca)*i/( AntagnistsCa)*i/( Antagnists;eneratin3

    First Se*n. Thir.

  • 8/13/2019 HIPERTENSI - Farmakoterapi

    7/9

    10/26/20

    Pen#e$at reseptor angiotensin II (3RB)

    Efe$ angiotensin II: 'aso$onstri$si& pelepasanaldosteron& a$ti'asi sipati$& pelepasan horon

    antidiureti$

    Beta blo!$er

    Ad$enose#to$ beta1 dan beta2 te$dist$ibusi di selu$uh tubuh

    eta 1:

    te$da#at ban"a di

  • 8/13/2019 HIPERTENSI - Farmakoterapi

    8/9

    10/26/20

    Reserpin

  • 8/13/2019 HIPERTENSI - Farmakoterapi

    9/9

    10/26/20

    *E;3S3N ISTI;3H BERI>T

    Pheo!hroo!#toa

    "rtostati$ hipotensi +hushing s#ndroe

    3theros$lerosis

    Hirsutise